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Introduction
Ulcerative colitis is an autoimmune disorder that
affects the gastrointestinal tract, in particularly the
colon. It can be defined as intermittent bouts of
inflammation within the colon that causes abdominal
pain, bloody stools, pus, and diarrhea (Zhang and Li,
2014). The lining of colon becomes irritated and
develops ulcers. The cause of the disease is still a
mystery; however, researchers believe that
environment, genetics, intestinal bacteria and the
individual’s immune response all play a role in one’s
susceptibility of the disease (Zhang and Li, 2014).
Ulcerative colitis is included under the umbrella group
of inflammatory bowel diseases. This disease can range
from moderate to severe symptoms, and can even be
fatal.

• The underlying pathophysiology of ulcerative
colitis can be described as inflammation and
ulceration of the mucosal lining of the colon.
• The inflammation usually starts within the area of
the rectum and progresses through the colon
(Harris & Jelemensky, 2014).
• The cause of ulcerative colitis is still unknown, but
researchers believe that immune system
abnormalities and genetics play a role. Risk factors
such as environmental factors, dietary habits, use of
oral contraceptives, and previous infections are also
under investigation (Harris & Jelemensky, 2014).
• Ulcerative colitis is “limited to the mucosal layers,
with varying degrees of infiltrates from
lymphocytes, plasma cells, and granulocytes, it also
includes the presence of Paneth cell metaplasia
which is indicative of chronic inflammation”
(Feuerstein & Chiefetz, 2014).
• Many research studies are underway regarding the
adaptive and innate immunologic process involved
in ulcerative colitis. Research has found a cytokine,
IL-23, which is a key process in the early response
to microbes, is found to be altered in patients with
ulcerative colitis, further suggesting its role in
chronic intestinal inflammation (Zhang & Li, 2014).

Significance of Pathophysiology
•

•
•
•

The significance of the pathophysiology of ulcerative
colitis is that researchers still do not know the cause of
the disease, but it is highly evident that there is an
immunologic alteration.
Ulcerative colitis is considered an auto-immune disorder,
as the body’s inflammation system is working in overtime.
Many of the treatments are aimed at decreasing
inflammation and reducing the body’s immune system.
Medications used for these factors include
aminosalycilates, corticosteroids, thiopurines, anti-tumor
necrosis factor agents, selective adhesion molecule
inhibitors and probiotics (Feuerstein & Chiefetz, 2014).

Conclusion
In conclusion, ulcerative colitis is a
complicated disease that still has a lot of
unknowns. As researchers continue to investigate
what may cause the disease, healthcare
professionals continue to best manage signs and
symptoms as best they can. Many of those with
ulcerative colitis fall under the category of having
mild to moderate symptoms, with only a small
percentage of patients having severe cases of the
disease. With this being said, most patients with
ulcerative colitis can be medically managed with
goals of prolonged periods of remission. Those
with severe cases of the disease may opt for
surgical management, by removing part or all of
colon. Researchers continue to look for reasons
that may trigger the body’s immune system to
attack itself. It is with great hope that researchers
can soon find a cause for this debilitating disease.
In hopes that one day healthcare professionals
can treat the disease more efficiently and/or
prevent it from occurring all together.
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Signs and Symptoms
•

•

•

Ulcerative colitis is a disease of intermittent flareups followed by periods of remission when no
signs or symptoms are present.
During a flare-up of ulcerative colitis, the signs
and symptoms can range from the following:
•
Abdominal pain and cramping
•
Blood or pus in the stool
•
Diarrhea
•
Frequent urgency to have bowel
movements
•
Tenesmus (Feuerstein & Chiefetz,
2014).
Other symptoms include nausea, low grade fever,
anemia and weight loss as well as extra intestinal
symptoms that include joint disorders and
arthritis (Harris & Jelemensky, 2014).

Diagnostic Criteria and Testing
•
•

•

•

•

Ulcerative colitis can be diagnosed by
sigmoidoscopy and biopsy.
In addition to obtaining a biopsy for
diagnosis, laboratory tests can also be
obtained.
Blood tests such as erythrocyte
sedimentation rate (ESR) and C-reactive
protein (CRP) can be collected to determine
inflammation within the body.
Stool studies can be obtained to rule out
other disorders such as infections caused
by toxins, bacteria, viruses or parasites.
The definitive diagnosis however, comes
from a colonoscopy and biopsy. (Harris &

Jelemensky, 2014).

Nursing Implications
The nursing role is extremely important in the
disease management of patients with ulcerative colitis.
•
Medication adherence can frequently be an issue in
patients with this disease, as there are periods of
time when there are no signs or symptoms. The
patient must be thoroughly educated by nursing to
take medication regularly regardless of symptoms
or not. This is important as the disease has periods
of remission followed by periods of flare-ups
(Dudley-Brown, 2012)
•
Open communication between the nurse and
patient can help combat a flare-up at the start of
symptoms instead of when the symptoms become
so bad that the patient needs to seek hospital
treatment.
•
Advanced practice nurses and nurses alike can
provide holistic care to patients by addressing not
only their physiological problems but also their
psychological problems involved with this disease
(Dudley-Brown, 2012).

(Image retrieved from:
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